DiaTech Oncology's Series B Round

DiaTech Oncology raised a round of funding on November 11, 2015. Investors include Keyholder Funding.

DiaTech Oncology is the provider of CorrectChemo, the drug response profiling test to help oncologists provide personalized cancer treatment. CorrectChemo is the only diagnostic test that delivers, wi…

Articles about DiaTech Oncology's Series B Round: